#UNSILENTCKD
LIVE

Serial Number

97931936

Owner

Renalytix AI, Inc.

Attorney

John Maldjian

Filing Date

May 11, 2023

Add to watchlist:

No watchlists yet
View on USPTO

#UNSILENTCKD Trademark

Serial Number: 97931936

#UNSILENTCKD is a trademark filed by Renalytix AI, Inc. on May 11, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Renalytix AI, Inc. (23 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 03

Trademark Details

Filing Date

May 11, 2023

Registration Date

Not Registered

Published for Opposition

May 28, 2024

Goods & Services

Providing online journals, namely, blogs, online non-downloadable newsletters, and non-downloadable webinars in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, kidney function, liver health, liver diseases, liver function, heart health, heart diseases, heart function, and the use of artificial intelligence for medical analysis; entertainment, information, and education services, namely, providing podcasts in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, kidney function, liver health, liver disease treatments, liver function, heart health, heart disease treatments, heart function, and the use of artificial intelligence for medical analysis; video production; arranging and conducting of conferences, symposia, and educational conferences in the field of health and medical information, kidney health, kidney disease, kidney disease treatments, kidney function, liver health, liver disease treatments, liver function, heart health, heart disease treatments, heart function, and the use of artificial intelligence for medical analysis; Educational services, namely, conducting informal on-line webinars in the fields of health and medical information, kidney health, kidney disease, kidney disease treatments, kidney function, liver health, liver disease treatments, liver function, heart health, heart disease treatments, heart function, and the use of artificial intelligence for medical analysis, and printable materials distributed therewith

Medical diagnostic test medias in the form of chemical reagent preparations for testing blood for medical purposes; reagents for use in diagnostic tests for medical purposes; test reagents for medical use; chemical reagent mixtures in kit form for medical use; diagnostic preparations for medical use in kit form; diagnostic reagents for medical use in kit form; diagnostic agents for pharmaceutical use in connection with kidney, heart, and liver diseases and disorders; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical laboratory use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; diagnostic substances for medical use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in kidney, heart, and liver health testing

Laboratory research in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; medical research services relating to kidney, heart, and liver health; Providing scientific research analysis and distribution therewith of informational reports based upon results of laboratory testing in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; providing temporary access to online, non-downloadable computer software for use in data management, data storage, data analysis, and report generation, all in the fields of laboratory and medical testing, kidney, heart, and liver health, and kidney, heart, and liver diseases

Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and test strips, and medical sample tubes, vials, and test strips for predicting, identifying and determining the risk of disease progression of the kidney, heart, and liver

Medical diagnostic testing and analysis services for treatment purposes; medical prognosis testing and analysis services for treatment purposes; advisory services relating to medical problems; providing custom treatment plans relating to health and medical problems; providing medical advice in the field of kidney, heart, and liver diseases and disorders; consultancy and advisory services in relation to medical care; medical advisory services; medical examination of individuals; medical health assessment services for treatment; medical screening; medical services; preparation of reports relating to medical matters; providing information including online about medical services; provision of medical information; medical advisory services relating to diseases; advisory services relating to health; preparation of reports relating to health care matters; information services relating to health care; Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease; medical profile and medical record analysis designed to provide patients with custom tailored information about the risk of progression of kidney, heart, and liver diseases and disorders

Promoting public awareness in the fields of health and medical information, kidney health, kidney disease, kidney disease treatments, kidney function, liver health, liver disease treatments, liver function, heart health, heart disease treatments, heart function, and the use of artificial intelligence for medical analysis

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 27, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jun 26, 2026 EX4G
SOU EXTENSION 4 FILED
Jun 26, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 26, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 24, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 23, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 23, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 23, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 17, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 16, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 16, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 23, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 23, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 23, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 14, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 14, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 14, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 14, 2025 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 23, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 5, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 5, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 11, 2023 NWOS
NEW APPLICATION ENTERED
May 15, 2023 NWAP